<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Oral calorie supplements for cystic fibrosis - Smyth, RL - 2017 | Cochrane Library</title> <meta content="Oral calorie supplements for cystic fibrosis - Smyth, RL - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000406.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Oral calorie supplements for cystic fibrosis - Smyth, RL - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000406.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000406.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Oral calorie supplements for cystic fibrosis" name="citation_title"/> <meta content="Rosalind L Smyth" name="citation_author"/> <meta content="UCL" name="citation_author_institution"/> <meta content="rosalind.smyth@ucl.ac.uk" name="citation_author_email"/> <meta content="Oli Rayner" name="citation_author"/> <meta content="University of Cambridge Biomedical Campus" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD000406.pub5" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/05/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000406.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000406.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000406.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Child Nutrition Disorders [*diet therapy, etiology]; Cystic Fibrosis [*complications]; *Dietary Supplements [adverse effects]; *Energy Intake; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000406.pub5&amp;doi=10.1002/14651858.CD000406.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="UDgTyLGV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000406\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000406\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000406.pub5",title:"Oral calorie supplements for cystic fibrosis",firstPublishedDate:"May 4, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Cystic Fibrosis and Genetic Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000406.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000406.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000406.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000406.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000406.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000406.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000406.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000406.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000406.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000406.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2719 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000406.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/full#CD000406-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/full#CD000406-sec-0087"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/full#CD000406-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/full#CD000406-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/full#CD000406-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/full#CD000406-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/full#CD000406-sec-0038"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/full#CD000406-sec-0081"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/table_n/CD000406StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/table_n/CD000406StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Oral calorie supplements for cystic fibrosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/information#CD000406-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Rosalind L Smyth</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000406.pub5/information#CD000406-cr-0005">Oli Rayner</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/information/en#CD000406-sec-0095">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 May 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000406.pub5">https://doi.org/10.1002/14651858.CD000406.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000406-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000406-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000406-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000406-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000406-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000406-abs-0001" lang="en"> <section id="CD000406-sec-0001"> <h3 class="title" id="CD000406-sec-0001">Background</h3> <p>Poor nutrition occurs frequently in people with cystic fibrosis and is associated with other adverse outcomes. Oral calorie supplements are used to increase total daily calorie intake and improve weight gain. However, they are expensive and there are concerns they may reduce the amount of food eaten and not improve overall energy intake. This is an update of a previously published review. </p> </section> <section id="CD000406-sec-0002"> <h3 class="title" id="CD000406-sec-0002">Objectives</h3> <p>To establish whether in people with cystic fibrosis, oral calorie supplements: increase daily calorie intake; and improve overall nutritional intake, nutritional indices, lung function, survival and quality of life. To assess adverse effects associated with using these supplements. </p> </section> <section id="CD000406-sec-0003"> <h3 class="title" id="CD000406-sec-0003">Search methods</h3> <p>We searched the Cochrane Cystic Fibrosis Trials Register comprising references from comprehensive electronic database searches, handsearches of relevant journals and abstract books of conference proceedings. We contacted companies marketing oral calorie supplements. </p> <p>Last search: 18 October 2016.</p> </section> <section id="CD000406-sec-0004"> <h3 class="title" id="CD000406-sec-0004">Selection criteria</h3> <p>Randomised or quasi‐randomised controlled trials comparing use of oral calorie supplements for at least one month to increase calorie intake with no specific intervention or additional nutritional advice in people with cystic fibrosis. </p> </section> <section id="CD000406-sec-0005"> <h3 class="title" id="CD000406-sec-0005">Data collection and analysis</h3> <p>We independently selected the included trials, assessed risk of bias and extracted data. We contacted the authors of included trials and obtained additional information for two trials. </p> </section> <section id="CD000406-sec-0006"> <h3 class="title" id="CD000406-sec-0006">Main results</h3> <p>We identified 21 trials and included three, reporting results from 131 participants lasting between three months and one year. Two trials compared supplements to additional nutritional advice and one to no intervention. Two of the included trials recruited only children. In one trial the risk of bias was low across all domains, in a second trial the risk of bias was largely unclear and in the third mainly low. Blinding of participants was unclear in two of the trials. Also, in one trial the clinical condition of groups appeared to be unevenly balanced at baseline and in another trial there were concerns surrounding allocation concealment. There were no significant differences between people receiving supplements or dietary advice alone for change in weight, height, body mass index, z score or other indices of nutrition or growth. Changes in weight (kg) at three, six and 12 months respectively were: mean difference (MD) 0.32 (95% confidence interval (CI) ‐0.09 to 0.72); MD 0.47 (95% CI ‐0.07 to 1.02 ); and MD 0.16 (‐0.68 to 1.00). Total calorie intake was greater in people taking supplements at 12 months, MD 265.70 (95% CI 42.94 to 488.46). There were no significant differences between the groups for anthropometric measures of body composition, lung function, gastro‐intestinal adverse effects or activity levels. Moderate quality evidence exists for the outcomes of changes in weight and height and low quality evidence exists for the outcomes of change in total calories, total fat and total protein intake as results are applicable only to children between the ages of 2 and 15 years and many post‐treatment diet diaries were not returned. Evidence for the rate of adverse events in the treatment groups was extremely limited and judged to be of very low quality </p> </section> <section id="CD000406-sec-0007"> <h3 class="title" id="CD000406-sec-0007">Authors' conclusions</h3> <p>Oral calorie supplements do not confer any additional benefit in the nutritional management of moderately malnourished children with cystic fibrosis over and above the use of dietary advice and monitoring alone. While nutritional supplements may be used, they should not be regarded as essential. Further randomised controlled trials are needed to establish the role of short‐term oral protein energy supplements in people with cystic fibrosis and acute weight loss and also for the long‐term nutritional management of adults with cystic fibrosis or advanced lung disease, or both. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000406-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000406-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD000406-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD000406-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000406-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD000406-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000406-abs-0005">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000406-abs-0002" lang="en"> <h3>Use of oral supplements to increase calorie intake in people with cystic fibrosis</h3> <p>We reviewed the evidence for the use of oral supplements to increase calorie intake in people with cystic fibrosis. </p> <p><b>Background</b> </p> <p>Cystic fibrosis affects many organs, including the digestive system, and can lead to food not being absorbed as it should be, which in turn leads to growth problems. Children with cystic fibrosis need more energy than other children, but they often have reduced appetites. Poor diet has been linked to poor outcomes in cystic fibrosis. Milks or juices containing additional calories are often added to the diets of children with cystic fibrosis to increase their total daily calorie intake and help them gain weight. However, these supplements are expensive and may not achieve the desired effect if patients take them as a substitute for calories consumed from food rather than as an additional component. In toddlers or young children use of supplements may risk compromising the development of normal eating behaviour. This is an updated version of the review. </p> <p><b>Search date</b> </p> <p>We last searched for evidence on 18 October 2016.</p> <p><b>Study characteristics</b> </p> <p>This review includes three randomised controlled trials with a total of 131 participants and two of them only included children. Two of the trials compared supplements to dietary advice and one compared supplements to no advice. The trials lasted between three months and one year. </p> <p><b>Key results</b> </p> <p>There were no major differences between people receiving supplements or just dietary advice for any nutritional or growth measurements. This was also true for measures of body composition, lung function, adverse effects on the digestive system or people's levels of activity. Advice and monitoring appear to be enough to manage the diet of moderately malnourished children. </p> <p>Future trials should look into the use of calorie supplements for acute weight loss or long‐term care for adults with cystic fibrosis. </p> <p><b>Quality of the evidence</b> </p> <p>One of the trials appeared to be well run and the risk of bias was low for all the aspects of trial design that we assessed; so we do not think any bias will influence the results in a negative way. In the other two trials, we were not sure if the people taking part could guess which treatment group they were in. In one of these two trials, we further thought it was likely that the person recruiting them to the trial knew which group the participant would be in. In the second of these trials, the people in the group receiving supplements appeared to be generally in better clinical condition at the start of the trial than those who didn't receive any supplements or advice. These factors affect our confidence in the results from these trials. </p> <p>We judged the quality of the evidence for the changes in weight and height to be moderate, but judged the quality of the evidence for the changes in total calories, total fat and total protein intake as low since results are applicable only to children aged between 2 and 15 years; also many post‐treatment diet diaries were not returned to the investigators. Evidence for the rate of adverse events in the treatment groups was extremely limited and judged to be of very low quality. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000406-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000406-sec-0087"></div> <h3 class="title" id="CD000406-sec-0088">Implications for practice</h3> <section id="CD000406-sec-0088"> <p>In children with CF who are moderately malnourished the use of dietary advice and monitoring alone is an appropriate approach to management. Nutritional supplements may be used but should not be regarded as an essential part of care. </p> </section> <h3 class="title" id="CD000406-sec-0089">Implications for research</h3> <section id="CD000406-sec-0089"> <p>The place of oral protein energy supplements in the short‐term management of people with CF and acute weight loss should be assessed in randomised controlled trials. The place of this intervention in the long‐term management of adults with CF or people with advanced lung disease, or both, should also be assessed in randomised controlled trials. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000406-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000406-sec-0008"></div> <div class="table" id="CD000406-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Oral calorie supplements compared with control for cystic fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: adults and children with cystic fibrosis </p> <p><b>Settings</b>: outpatients </p> <p><b>Intervention</b>: oral calorie supplements </p> <p><b>Comparison</b>: control (no intervention, dietary advice or nutritional counselling) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control (no intervention, dietary advice or nutritional counselling)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Oral calorie supplements</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in weight (kg):<sup>1</sup> </b> at 12 months </p> <p>Follow‐up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in weight was 2.97 kg gained in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in weight was 0.16 kg extra gained (0.68 kg lost to 1.00 kg extra gained) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was also no significant difference between treatment groups at 3 months (MD 0.32 kg, 95% CI ‐0.09 kg to 0.72 kg, 112 participants, 2 trials) or at 6 months (MD 0.47 kg, 95% CI ‐0.07 kg to 1.02 kg, 117 participants, 2 trials). </p> <p>There was also no significant difference in change in weight centile between treatment groups at 3, 6 and 12 months. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in height (cm):<sup>1</sup> </b> </p> <p>at 12 months</p> <p>Follow‐up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in height was 5.85 cm gained in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in height was 0.06 cm extra gained (0.50 cm lost to 0.62 cm extra gained) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was also no significant difference between treatment groups at 3 months (MD ‐0.04 cm, 95% CI ‐0.36 cm to 0.29 cm, 112 participants, 2 trials) or at 6 months (MD ‐0.47 cm, 95% CI ‐1.32 cm to 0.38 cm, 101 participants, 1 trial). </p> <p>There was also no significant difference in change in height centile between treatment groups at 3, 6 and 12 months. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in total calories (Kcal/day)</b>: </p> <p>at 12 months</p> <p>Follow‐up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total calories was 139.52 Kcal/day in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total calories was 265.70 Kcal/day higher (42.94 to 488.46 Kcal/day higher) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/>(1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was also a significant advantage to the treatment group over the control group at 6 months (MD 304.86 Kcal/day, 95% CI 5.62 kcal/day to 604.10 Kcal/day, 48 participants, 1 trial). </p> <p>There was no significant difference between treatment groups at 3 months (MD 115.09 Kcal/day, 95% CI ‐121.34 Kcal/day to 351.52 Kcal/day, 58 participants, 2 trials). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in total protein (g/day)</b>: </p> <p>at 12 months</p> <p>Follow‐up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total protein was 5.75 g/day in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total calories was 6.82 g/day higher (2.36 g/day lower to 16.00 g/day higher) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/>(1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was also no significant difference between treatment groups at 3 months (MD 2.51 g/day, 95% CI ‐6.74 g/day to 11.77 g/day, 58 participants, 2 trials) or at 6 months (MD 8.77 g/day, 95% CI ‐1.24 g/day to 18.78 g/day, 48 participants, 1 trial). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in total fat (g/day)</b>: </p> <p>at 12 months</p> <p>Follow up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total fat was 12.23 g/day in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total calories was 8.85 g/day higher (4.64 g/day lower to 22.34 g/day higher) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/>(1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was also no significant difference between treatment groups at 3 months (MD ‐1.10 g/day, 95% CI ‐15.05 g/day to 12.85 g/day, 58 participants, 2 trials) or at 6 months (MD 11.74 g/day, 95% CI ‐2.96 g/day to 26.44 g/day, 48 participants, 1 trial). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b>: </p> <p>Follow up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>4</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One trial investigated gastro‐intestinal symptoms with a questionnaire and reported no significant difference between the groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in lung function ‐ FEV₁ (% predicted):</b> </p> <p>at 12 months</p> <p>Follow‐up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in FEV₁ (% predicted) was ‐1.5 in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in FEV₁ (% predicted) 1.91 lower (8.57 lower to 4.75 higher) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70<br/>(1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>2,5</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was a significant decline in FEV₁ (% predicted) in the treatment group compared to the control group at 3 months (MD ‐7.96, 95% CI ‐13.52 to ‐2.40). There was no significant difference between treatment groups at 6 months (MD ‐3.39, 95% CI ‐9.97 to 3.19). </p> <p>There was also no significant difference in change in FVC between treatment groups at 3, 6 and 12 months. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the mean control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>BMI</b> : body mass index; <b>CI</b> : confidence interval; <b>FEV₁</b> : forced expiratory volume at 1 second; <b>FVC</b> : forced vital capacity; <b>MD</b> : mean difference; <b>NA</b>: not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. There was also no significant difference in terms of other indices of nutrition or growth; weight for height (percentage) at 3 months, change in BMI (kg/m²) at 3, 6 and 12 months and change in BMI centile at 3 and 12 months. There was a significant advantage for oral calorie supplements over control at 6 months (MD 5.75, 95% CI 0.22 to 11.28, 101 participants, 1 trial). </p> <p>2. Downgraded once due to applicability; results apply only to children between the ages of 2 and 15 years, results not applicable to adults. </p> <p>3. Downgraded once due to incomplete outcome data; 58 out of 102 children returned the 12 month dietary diary, 44 who did not return the diary are excluded from analysis. </p> <p>4. Downgraded twice due to imprecision and once due to risk of selective outcome reporting bias; adverse events of treatment were reported in only a single trial and very limited information was provided about the rate of adverse events. </p> <p>5. Downgraded once due to applicability; Spirometry data recorded only for children over the age of 5 years, lung function outcomes are not applicable to children between the ages of 2 to 5 years from this study. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000406-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000406-sec-0009"></div> <section id="CD000406-sec-0010"> <h3 class="title" id="CD000406-sec-0010">Description of the condition</h3> <p>Cystic fibrosis (CF) is a multisystem disorder affecting many organs including the lungs, gastro‐intestinal tract, pancreas and liver. Failure to thrive is a common means of presentation of undiagnosed children with CF; and poor nutrition may be a problem in the children and adults diagnosed with CF (<a href="./references#CD000406-bbs2-0029" title="ShepherdR , CooksleyWGE , CookeWDD . Improved growth and clinical, nutritional and respiratory changes in response to nutritional therapy in cystic fibrosis. Journal of Pediatrics1980;97(3):351-7.">Shepherd 1980</a>). This may worsen as the disease progresses. In recent years guidelines have recommended that dietary intake should provide at least 120% of the recommended daily allowance for energy in people with cystic fibrosis (<a href="./references#CD000406-bbs2-0031" title="SinaasappelM , SternM , LittlewoodJ , WolfeS , SteinkampG , HeijermanHG . Nutrition in patients with cystic fibrosis; a European consensus. Journal of Cystic Fibrosis2002;1(4):51-75.">Sinaasappel 2002</a>). This increased calorie requirement is contributed to by multiple factors. These include malabsorption and, in children or adults with more advanced chest disease, it may also be contributed to by increased work of breathing or chronic pulmonary sepsis. In addition, when unwell, people with CF may have reduced appetite. It was suggested by studies in the 1980s that there was an increased energy requirement associated with the basic defect of CF (<a href="./references#CD000406-bbs2-0030" title="ShepherdRW , HoltTL , Vasques-VelasquezL , CowardWA , PrenticeA , LucasA . Increased energy expenditure in young children with cystic fibrosis. Lancet1988;I(8598):1300-3.">Shepherd 1988</a>), but this is now disputed and resting energy expenditure in clinical stable children with CF has been shown to be similar to control children without CF (<a href="./references#CD000406-bbs2-0026" title="MarinVB , VelandiaS , HunterB , GattasV , FielbaumO , HerraraO , et al. Energy expenditure, nutrition status and body composition in children with cystic fibrosis. Nutrition2004;20(2):181-6.">Marin 2004</a>). Poor nutrition has been associated with adverse outcomes in CF and therefore nutritional management is directed at maintaining normal weight and height for age in people with CF (<a href="./references#CD000406-bbs2-0025" title="MacDonaldA . Nutritional management of cystic fibrosis. Archives of Disease in Childhood1996;74(1):81-7.">MacDonald 1996</a>). There is a further systematic review which assesses the effectiveness of this intervention for children with chronic disease (<a href="./references#CD000406-bbs2-0024" title="FrancisDK , SmithJ , SaljuqiT , WatlingRM . Oral protein calorie supplementation for children with chronic disease. Cochrane Database of Systematic Reviews2015, Issue 5. Art. No: CD001914. [DOI: 10.1002/14651858.CD001914.pub2]">Francis 2015</a>). </p> </section> <section id="CD000406-sec-0011"> <h3 class="title" id="CD000406-sec-0011">Description of the intervention</h3> <p>Oral calorie supplements (OCS) are usually in the form of either fortified milk or juice drinks or simple energy sources. </p> </section> <section id="CD000406-sec-0012"> <h3 class="title" id="CD000406-sec-0012">How the intervention might work</h3> <p>These supplements are used to try and increase the total daily calorie intake and thereby improve weight gain. Provided calorie supplements are taken in addition to normal dietary intake from food, then overall calorie intake should be improved. </p> </section> <section id="CD000406-sec-0013"> <h3 class="title" id="CD000406-sec-0013">Why it is important to do this review</h3> <p>However, it is possible that OCS may replace some of the calories taken as food and their potential effect on overall total calorie intake be either reduced or eliminated. A further potential adverse consequence of replacing calorie intake from normal food by calories from OCS may be to have a detrimental effect on normal eating behaviour, which is particularly critical in toddlers and young children who are learning to develop normal eating behaviour. In addition, OCS are expensive and therefore it is important to evaluate their effectiveness. The cost for a 10‐year old child is about £1124 per annum in the UK (<a href="./references#CD000406-bbs2-0028" title="Royal Liverpool Children's Hospital NHS Trust [Pharmacy]. Personal communication2006.">RLCH 2006</a>). </p> <p>This is an updated version of previously published reviews (<a href="./references#CD000406-bbs2-0035" title="SmythRL , WaltersS . Oral calorie supplements for cystic fibrosis. Cochrane Database of Systematic Reviews2000, Issue 1. Art. No: CD000406. [DOI: 10.1002/14651858.CD000406]">Smyth 2000</a>; <a href="./references#CD000406-bbs2-0036" title="SmythRL , WaltersS . Oral calorie supplements for cystic fibrosis. Cochrane Database of Systematic Reviews2007, Issue 1. Art. No: CD000406. [DOI: 10.1002/14651858.CD000406.pub2]">Smyth 2007</a>; <a href="./references#CD000406-bbs2-0037" title="SmythRL , WaltersS . Oral calorie supplements for cystic fibrosis. Cochrane Database of Systematic Reviews2012, Issue 10. Art. No: CD000406. [DOI: 10.1002/14651858.CD000406.pub3]">Smyth 2012</a>; <a href="./references#CD000406-bbs2-0038" title="SmythRL , RaynerO . Oral calorie supplements for cystic fibrosis. Cochrane Database of Systematic Reviews2014, Issue 11. Art. No: CD000406. [DOI: 10.1002/14651858.CD000406.pub4]">Smyth 2014</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000406-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000406-sec-0014"></div> <p>To examine the evidence that in people with CF oral calorie supplements:</p> <p> <ul id="CD000406-list-0001"> <li> <p>improve measures of nutritional status, lung function and survival and quality of life; </p> </li> <li> <p>increase daily calorie intake, without reducing calorie intake from normal food;</p> </li> <li> <p>are associated with adverse effects in people with CF, which are either important to the individual or have long‐term sequelae. These may include diarrhoea, reduced appetite, and bloating. </p> </li> </ul> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000406-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000406-sec-0015"></div> <section id="CD000406-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000406-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs), published or unpublished. Trials, where quasi‐randomisation methods such as alternation are used, would be included if there was sufficient evidence that the treatment and comparison groups were comparable in terms of clinical and nutritional status. </p> </section> <section id="CD000406-sec-0018"> <h4 class="title">Types of participants</h4> <p>Children and adults with defined CF, diagnosed clinically and by sweat or genetic testing, including all ages and all degrees of severity, including severity of undernutrition. </p> </section> <section id="CD000406-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Oral calorie supplements, in the form of either fortified milk or juice drinks or as simple energy sources, given in any amount for a period of at least one month, where these have been compared to existing conventional therapies in people with CF. Existing conventional therapies may include nutritional advice on how to improve calorie input from food or no specific intervention. These two control groups will be analysed separately when there are sufficient studies available. Trials where OCS are used for reasons other than to increase calorie intake were excluded. </p> </section> <section id="CD000406-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD000406-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD000406-list-0002"> <li> <p>Change in weight or height or body mass index (BMI) or z score or other indices of nutrition or growth </p> </li> </ol> </p> </section> <section id="CD000406-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD000406-list-0003"> <li> <p>Anthropometric measures of body composition</p> </li> <li> <p>Total calorie intake measured daily or weekly or over some other time interval</p> </li> <li> <p>Calorie intake from food measured daily, weekly or over some other time interval</p> </li> <li> <p>Calorie intake from OCS measured daily, weekly or over some other time interval</p> </li> <li> <p>Nutrient intake measured daily, weekly or at some other time interval</p> </li> <li> <p>Measures of eating behaviour</p> </li> <li> <p>Measures of quality of life</p> </li> <li> <p>Adverse effects including diarrhoea, reduced appetite, abdominal bloating, episodes of distal intestinal obstruction syndrome and any other adverse effects reported </p> </li> <li> <p>Measures of lung function</p> </li> <li> <p>Number of deaths or age at death in each group</p> </li> <li> <p>Activity levels (post hoc change)</p> </li> </ol> </p> </section> </section> </section> <section id="CD000406-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>There will be no restrictions regarding language or publication status.</p> <section id="CD000406-sec-0024"> <h4 class="title">Electronic searches</h4> <p>Relevant trials were identified from the Group's Cystic Fibrosis Trials Register using the terms: calorie supplements AND oral. </p> <p>The Cystic Fibrosis Trials Register is compiled from electronic searches of the Cochrane Central Register of Controlled Trials (CENTAL) (updated each new issue of the <i>Cochrane Library</i> ), weekly searches of MEDLINE, a search of Embase to 1995 and the prospective handsearching of two journals ‐ <i>Pediatric Pulmonology</i> and the <i>Journal of Cystic Fibrosis</i>. Unpublished work is identified by searching the abstract books of three major cystic fibrosis conferences: the International Cystic Fibrosis Conference; the European Cystic Fibrosis Conference and the North American Cystic Fibrosis Conference. For full details of all searching activities for the register, please see the relevant sections of the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/CF/frame.html" target="_blank">Cystic Fibrosis and Genetic Disorders Group Module</a>. </p> <p>Date of the most recent search of the Group's CF Trials Register: 18 October 2016.</p> </section> <section id="CD000406-sec-0025"> <h4 class="title">Searching other resources</h4> <p>In addition, full text searching of the <i>Journal of Pediatrics</i> from 1988 to 1996 was undertaken. Additional RCTs were found from the reference lists provided by the review group. Furthermore, the companies which manufacture OCS were contacted to ask whether they have data on RCTs of OCS in CF on file. </p> </section> </section> <section id="CD000406-sec-0026"> <h3 class="title" id="CD000406-sec-0026">Data collection and analysis</h3> <section id="CD000406-sec-0027"> <h4 class="title">Selection of studies</h4> <p>The two authors independently selected the trials to be included in the review. Any disagreements were resolved by discussion. </p> </section> <section id="CD000406-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Each author independently extracted data and again any disagreements were resolved by discussion. </p> <p>Outcome data were grouped into those measured at one, three, six, 12 months and annually thereafter. If outcome data were recorded at other time periods then consideration was given to examining these as well. </p> </section> <section id="CD000406-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>In order to establish a risk of bias for each included trial, each author assessed the methodological quality of each trial. In particular, authors examined details of generation of the randomisation sequence and allocation concealment. If these were considered adequate the authors deemed the trial to be at low risk of bias. The authors also assessed whether the trial was blinded. The more people blinded to an intervention (participants, clinicians and outcome assessors), the lower the risk of bias would be for that trial. The authors also examined whether intention‐to‐treat analyses were possible from the available data and if the number of participants lost to follow up or subsequently excluded from the trial was recorded. Any trials which did not discuss or account for missing data or participants was thought to have a potential risk of bias. For quasi‐randomised studies, each author examined the baseline characteristics of the intervention and comparison groups to assess whether the two groups were comparable. If groups were not comparable, there would be a risk of bias. </p> </section> <section id="CD000406-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>For binary outcome measures, we aimed to calculate a pooled estimate of the treatment effect for each outcome across trials (the odds of an outcome among treatment allocated participants to the corresponding odds among controls). For continuous outcomes, we recorded either mean change from baseline for each group or mean post‐treatment/intervention values and standard deviation or standard error for each group. We aimed to calculate a pooled estimate of treatment effect by determining the mean difference (MD) and corresponding 95% confidence intervals (CIs). </p> </section> <section id="CD000406-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>We do not plan to include any cross‐over trials as this design is not appropriate to assess the effect of the intervention or the above‐mentioned outcomes. </p> </section> <section id="CD000406-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>In order to allow an intention‐to‐treat analysis, we sought data on the number of participants with each outcome event, by allocated treated group, irrespective of compliance and whether or not the participant was later thought to be ineligible or otherwise excluded from treatment or follow up. </p> <p>Where data were not available in the published trial reports, we contacted the lead investigator of the trial for further information. </p> </section> <section id="CD000406-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned that heterogeneity between trial results would be tested for using a standard Chi² test. </p> </section> <section id="CD000406-sec-0034"> <h4 class="title">Data synthesis</h4> <p>We analysed the data using a fixed‐effect model. We had originally planned to analyse data using a random‐effects model if we had identified significant heterogeneity between trials. </p> </section> <section id="CD000406-sec-0035"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We originally planned to perform subgroup analyses stratified according to type of control group(s) used, age and severity of nutritional status. </p> </section> <section id="CD000406-sec-0036"> <h4 class="title">Sensitivity analysis</h4> <p>We also planned to perform a sensitivity analysis based on the methodological quality of the trials, including and excluding quasi‐randomised trials. </p> </section> <section id="CD000406-sec-0037"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>In a post hoc change from protocol, we have presented a summary of findings tables for the comparison of oral calorie supplements compared to control (no intervention, dietary advice or nutritional counselling) for adults and children with CF (<a href="./full#CD000406-tbl-0001">summary of findings Table 1</a>). </p> <p>The following outcomes were reported in the tables (chosen based on relevance to clinicians and consumers): change in weight (kg), change in height (cm), change in total calories (kcal/day), change in total protein (g/day), change in total fat (g/day), adverse events, lung function (change in per cent (%) predicted FEV₁). All outcomes are reported at 12 months. </p> <p>We determined the quality of the evidence using the GRADE approach; and downgraded evidence in the presence of a high risk of bias in at least one study, indirectness of the evidence, unexplained heterogeneity or inconsistency, imprecision of results, high probability of publication bias. We downgraded evidence by one level if they considered the limitation to be serious and by two levels if very serious. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000406-sec-0038" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000406-sec-0038"></div> <section id="CD000406-sec-0039"> <h3 class="title">Description of studies</h3> <section id="CD000406-sec-0040"> <h4 class="title">Results of the search</h4> <p>The searches for this review identified a total of 22 potentially eligible trials. Three trials were included in the review; 18 trials were excluded from the review; and one trial is awaiting classification. </p> </section> <section id="CD000406-sec-0041"> <h4 class="title">Included studies</h4> <p>All three included trials (n = 131) have been published as abstracts and full papers (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). </p> <section id="CD000406-sec-0042"> <h5 class="title">Trial design</h5> <p>Two trials were RCTs (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>) and one was a quasi‐RCT (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). All three were of parallel design (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). Two trials were single centre (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>) and one was multicentre with included participants recruited from 17 hospitals (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). All three trials had differing durations: in one the intervention was given for three months with a total of six months follow‐up (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>); in the second trial the intervention was given for six months (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>); and in the third trial, the intervention was given for 12 months (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). </p> <p>One trial was an explanatory trial (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>) (an explanatory trial is one which looks at biological mechanisms, rather than one which aims to provide sound treatment recommendations (<a href="./references#CD000406-bbs2-0027" title="MurrayGD . Statistical aspects of research methodology. British Journal of Surgery1991;78(7):777-81.">Murray 1991</a>)). The main aim of this trial was to investigate the relationship between nutritional status and skeletal muscle strength. Since they are investigating the biological effects of treatment, explanatory trials usually only analyse the information on individuals who completed treatment, which was the case in this trial. Two trials presented data using an ITT analysis (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). </p> </section> <section id="CD000406-sec-0043"> <h5 class="title">Participants</h5> <p>Numbers of participants ranged from 15 (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>) to 102 (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). Two trials enrolled children up to 15 years of age (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>) and one trial included both children and adults (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). In two studies there were almost equal numbers of males and females (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>), but in one trial there were more females (n = 10) than males (n = 3) (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). </p> <p>All trials supplied details of participant characteristics at baseline (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). In the Hanning trial, although the participants were described as having mild to moderate lung disease and were randomised with adequate allocation concealment, the treatment and control groups were not similar at baseline; the treatment group appearing to be in better clinical condition (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>). </p> <p>Two trials stated inclusion criteria: for the Kalnins trial these were below 90% ideal weight for height or a 5% reduction in ideal weight for height over three months (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>); and in the CALICO trial at least one of the following ‐ a BMI below the 25th centile but over 0.4th centile, or no increase in weight over the previous three months, or a 5% decrease in weight from baseline over a period shorter than six months (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). </p> </section> <section id="CD000406-sec-0044"> <h5 class="title">Interventions</h5> <p>The interventions in the included trials were targeted to achieve an increase in energy intake of 20% (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>) or 25% (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>). Two trials compared dietary advice in addition to supplements in the form of drinks to dietary advice alone (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). One trial compared the use of dietary supplements (drink powders, milk shakes or tinned puddings) to a control group receiving no additional supplements (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>). </p> </section> <section id="CD000406-sec-0045"> <h5 class="title">Outcomes</h5> <p>All three trials reported on dietary energy and nutrient intake, height, weight, anthropometric measurements and pulmonary function (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). Two trials reported on activity levels (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). Hanning additionally reported on skeletal muscle strength and power, respiratory muscle strength and laboratory measures of nutritional status (e.g. albumin, amino acids) (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>). Kalnins additionally reported weight for height scores and faecal balance studies (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). Poustie reported BMI scores and gastro‐intestinal symptoms (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). </p> </section> </section> <section id="CD000406-sec-0046"> <h4 class="title">Excluded studies</h4> <p>A total of 18 trials were excluded for a variety of reasons. Details can be found in the section <a href="./references#CD000406-sec-0103" title="">Characteristics of excluded studies</a>. </p> <p>Seven trials did not use an oral calorie supplement in the intervention (<a href="./references#CD000406-bbs2-0004" title="AbdulhamidI , BeckFW , MillardS , ChenX , PrasadA . Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatric Pulmonology2008;43(3):281-7. AbdulhamidI , MillardS , BeckF , ChenX , vanWagnenC , PrasadA . Effect of zinc supplementation on respiratory tract infections in children with cystic fibrosis. Pediatric Pulmonology2005;40(Suppl 28):348. ">Abdulhamid 2008</a>; <a href="./references#CD000406-bbs2-0007" title="BruzzeseE , RaiaV , SpagnuoloMI , VolpicelliM , De MarcoG , MaiuriL , et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clinical Nutrition2007;26(3):322-8. ">Bruzzese 2007</a>; <a href="./references#CD000406-bbs2-0009" title="EllisL , KalninsD , CoreyM , BrennanJ , PencharzP , DurieP . Do infants with cystic fibrosis need a protein hydrolysate formula? A prospective, randomized, comparative study. Journal of Pediatrics1998;132:270-6. ">Ellis 1998</a>; <a href="./references#CD000406-bbs2-0011" title="HaworthCS , JonesA , SelbyPL , AdamsJE , MawerEB , WebbAK . Randomised, double blind, placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adults with cystic fibrosis [abstract]. Pediatric Pulmonology2001;32(Suppl 22):330-1. HaworthCS , JonesAM , AdamsJE , SelbyPL , WebbAK . Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis. Journal of Cystic Fibrosis2004;3(4):233-6. ">Haworth 2004</a>; <a href="./references#CD000406-bbs2-0014" title="Lloyd-StillJ , PowersCA , HoffmanDR , Boyd-TrullK , LesterLA , BenisekDC , et al. A randomized, controlled study examining the bioavailability and safety of an algal docosahexaenoic acid (DHA) triacylglycerol in cystic fibrosis (CF) patients. Pediatric Pulmonology2004;38(Suppl 27):331. Lloyd-StillJD , PowersCA , HoffmanDR , ArterburnLM , BenisekDC , LesterLA . Bioavailability and safety of an algal docosahexaenoic acid (DHA) triglyceride in cystic fibrosis (CF). Pediatric Research2001;49(4 Suppl):455a. Lloyd-StillJD , PowersCA , HoffmanDR , Boyd-TrullK , ArterburnLM , BenisekDC , et al. Blood and tissue essential fatty acids after docosahexaenoic acid supplementation in cystic fibrosis. Pediatric Pulmonology2001;Suppl 22:263. Lloyd-StillJD , PowersCA , HoffmanDR , Boyd-TrullK , LesterLA , BenisekDC , et al. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study. Nutrition2006;22(1):36-46. PowersCA , Lloyd-StillJD , HoffmanDR , ArterburnLM , BenisekDC , LesterLA . Lipid soluble antioxidant status during supplementation with algal docosahexaenoic acid triglyceride in CF. In: 24th European Cystic Fibrosis Conference; 2001 June 6-9; Vienna, Austria. 2001:P133. ">Lloyd‐Still 2001</a>; <a href="./references#CD000406-bbs2-0017" title="OudshoornJH , KlijnPH , HofmanZ , VoorbijHA , van derEntCK , BergerR , et al. Dietary supplementation with multiple micronutrients: no beneficial effects in pediatric cystic fibrosis patients. Journal of Cystic Fibrosis2007;6(1):35-40. ">Oudshoorn 2007</a>; <a href="./references#CD000406-bbs2-0018" title="PapasK , KalbfleischJ , MohonR . Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients. Digestive Diseases and Sciences2007;52(2):347-52. ">Papas 2007</a>). Four trials did not give an oral calorie supplement with the objective of increasing calorie intake (<a href="./references#CD000406-bbs2-0006" title="BestK , McCoyK , GemmaS , DisilvestroRA . Copper enzyme activities in cystic fibrosis before and after supplementation plus or minus zinc. Metabolism2004;53(1):37-41. ">Best 2004</a>; <a href="./references#CD000406-bbs2-0008" title="CaramiaG , CocchiM , GagliardiniR , MalavoltaM , MozzonM , FregaNG . Fatty acids composition of plasma phospholipids and triglycerides in children with cystic fibrosis. The effect of dietary supplementation with an olive and soybean oils mixture. Pediatria Medica E Chirurgica2003;25(1):42-9. ">Caramia 2003</a>; <a href="./references#CD000406-bbs2-0010" title="GreyV , MohammedSR , SmountasA , BahloolR , LandsL . Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. Journal of Cystic Fibrosis2003;2(4):195-8. LandsLC , GreyVL . Oral supplementation with a bovine whey protein isolate can increase intracellular and sputum glutathione levels in patients with cystic fibrosis. Pediatric Pulmonology2000;Suppl 20:253. ">Grey 2003</a>; <a href="./references#CD000406-bbs2-0016" title="MillaC , DohertyL , RaatzS , SchwarzenbergSJ , RegelmannW , MoranA . Glycemic response to dietary supplements in cystic fibrosis is dependent on the carbohydrate content of the formula. Journal of Parenteral and Enteral Nutrition1996;20:182-6. ">Milla 1996</a>). Three trials were of insufficient duration (less than one month) (<a href="./references#CD000406-bbs2-0005" title="AddeFV , DolceP , TanikawaCE , UeharaDY , CardosoAL , RozovT . [Nutritional supplementation in patients with cystic fibrosis] [Suplementacao dietetica em pacientes com fibrose cistica]. Jornal de Pediatria1997;73(5):317-23. [CENTRAL: 1200048] [CFGD REGISTER: GN260] [PMID: 14685384]">Adde 1997</a>; <a href="./references#CD000406-bbs2-0012" title="KaneRE , HobbsP . Energy and respiratory metabolism in cystic fibrosis: the influence of carbohydrate content of nutritional supplements. Journal of Pediatric Gastroenterology and Nutrition1991;12:217-23. ">Kane 1991</a>; <a href="./references#CD000406-bbs2-0020" title="SondelSA , ParrellSW , BeckerD , MischlerEH . Oral nutritional supplementation in cystic fibrosis. Nutritional Support Services1987;7(4):20-2. ">Sondel 1987</a>). One trial was not randomised (<a href="./references#CD000406-bbs2-0019" title="BarrettJ . A study to assess the efficacy of Healthshake in the nutritional management of children and adults with cystic fibrosis. Start date: 1/7/98; End date: 30/6/99. National Research Register (UK) www.update-software.com/national/2001. PatchellC . Personal Communication March 05 2001. ">Patchell 2001</a>) and a further trial was a quasi‐RCT, but the groups were not comparable at baseline (<a href="./references#CD000406-bbs2-0021" title="KoletzkoB , Ruhl-BagheriI , ThielI , SteinkampG . Effects of a formula supplement rich in linoleic acid on the essential fatty acid status of cystic fibrosis patients [abstract]. Clinical Nutrition1992;11(Suppl):39-40. SteinkampG , DemmelmairH , Ruhl-BagheriI , von derHardtH , KoletzkoB . Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients. Journal of Pediatric Gastroenterology and Nutrition2000;31:418-23. ">Steinkamp 2000</a>). One trial did not have a comparator group without an oral supplement (<a href="./references#CD000406-bbs2-0013" title="LepageG , YesairDW , RoncoN , ChampagneJ , Bureau N , ChemtobS , et al. Effect of an organized lipid matrix on lipid absorption and clinical outcomes in patients with cystic fibrosis. Journal of Pediatrics2002;141(2):178-85. ">Lepage 2002</a>) and in one trial the calorie supplement was not given orally (<a href="./references#CD000406-bbs2-0015" title="McKennaMC , HubbardVS , BieriJG . Linoleic acid absorption from lipid supplements in patients with cystic fibrosis with pancreatic insufficiency and in control subjects. Journal of Pediatric Gastroenterology and Nutrition1985;4(1):45-51. ">McKenna 1985</a>). </p> </section> </section> <section id="CD000406-sec-0047"> <h3 class="title">Risk of bias in included studies</h3> <section id="CD000406-sec-0048"> <h4 class="title">Allocation</h4> <p>In the trial by Hanning and the CALICO trial, generation of the randomisation sequence was based on a table of random numbers and so we judged these trials to have a low risk of bias (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). In the trial by Kalnins, participants were segregated by age and sex and the initial participants from each group were randomly allocated to intervention or control (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). The paper does not give any details of how this randomisation was undertaken, so we deemed this trial to have an unclear risk of bias (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). </p> <p>Allocation in the Hanning trial and the CALICO trial was concealed using sealed envelopes and we judged these trials to have a low risk of bias (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). The trial by Kalnins was quasi‐randomised, initial participants from each group were randomly allocated to intervention or control, then each subsequent participant was allocated a different group from the previous one (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). We therefore judged this trial to have a potential risk of bias. </p> </section> <section id="CD000406-sec-0049"> <h4 class="title">Blinding</h4> <p>Due to the interventions, blinding of clinicians and participants was not possible in any of the three included trials, but all three trials blinded the outcome assessors for some or all outcomes. In the Hanning trial, investigators performing skeletal and lung muscle‐function tests and anthropometry were unaware of the participant's study group (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>). In the CALICO trial, the researcher undertaking the analysis of outcomes was masked as to the allocation groups (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). These two trials were deemed to have some risk of bias. In the Kalnins trial apart from the 'study monitors' (nurse and dietitian), all other investigators were blinded (but it was not clear whether all investigators who assessed the outcome measures were blinded) (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). Due to this fact the risk of bias for this trial is unclear. </p> </section> <section id="CD000406-sec-0050"> <h4 class="title">Incomplete outcome data</h4> <p>In the Hanning trial, an intention‐to‐treat analysis was not performed (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>); 20 participants were randomised but data from only 16 participants were presented. The paper does give reasons for the four participants withdrawing (they found the time demands for testing or the travelling distance to be excessive) (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>). We therefore judged this trial to have a low risk of bias from incomplete outcome data. </p> <p>In the Kalnins trial, two participants (one in each group) dropped out after completing baseline (reasons were feeling unwell and change of mind) and were not followed up (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). Two out of seven participants allocated to the supplement group were not taking supplements at three months, but were included in the analysis, which was judged to be intention to treat (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). We judged there to be some risk of bias in this trial since although the withdrawals were described and the analysis was by intention to treat, the drop outs were not equal across groups. </p> <p>In the CALICO trial, analysis was by intention to treat (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). It was stated that all 102 children randomised completed the trial; however there were some data not available for some of the outcomes. Interim data on two children from the supplement group (due to parental choice or illness) and on one child from the standard care group (due to illness) were not collected. We judged there to be little risk of bias here as the drop outs were equal across groups and for similar reasons. Furthermore, nine children failed to return the baseline diet diary and 39 failed to return the 12‐month diet diary (no details given for which group these children were allocated to), so dietary intake data are based on the 58 children who completed both diaries. Spirometry data are available for 70 of the 72 children who were aged over five years, again no details are given as to which group the two missing sets of data were from. </p> </section> <section id="CD000406-sec-0051"> <h4 class="title">Selective reporting</h4> <p>Two trials had an unclear risk of bias as they did not report adverse events; however it was unclear if this was due to a lack of adverse events or a failure to report them (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). Kalnins did not report the change from baseline values for outcome measures in the original publication, but has since provided summary statistics for the change from baseline to the authors of this review (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). One trial was judged to have a low risk of bias for selective reporting as all outcomes described in the 'Methods' section of the full paper are reported in the 'Results' section (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). </p> </section> <section id="CD000406-sec-0052"> <h4 class="title">Other potential sources of bias</h4> <p>In the Hanning trial, it was noted that the participants in the treated group appeared to be in better clinical condition at baseline than in the control group (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>). This could potentially be a source of bias. </p> </section> </section> <section id="CD000406-sec-0053"> <h3 class="title" id="CD000406-sec-0053">Effects of interventions</h3> <p>See: <a href="./full#CD000406-tbl-0001"><b>Summary of findings 1</b> Summary of findings</a> </p> <p>It should be noted that the total number of participants included in this review was 131; 16 from one trial (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>), 13 from the second trial (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>) and 102 from the third trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). In the Hanning trial, the groups were not similar at baseline, therefore we have not included these results. We have attempted, as yet unsuccessfully, to obtain further information from the authors, in particular the mean change from baseline for all outcomes relevant to the review and data on the four participants who dropped out, to enable an intention‐to‐treat analysis. </p> <p>The majority of the participants in this review were from the CALICO trial. Where possible, the outcomes measured at three and six months from the Kalnins and Hanning trials are combined with the CALICO trial. All the outcomes reported at 12 months are from the CALICO trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). </p> <section id="CD000406-sec-0054"> <h4 class="title">Primary outcome</h4> <section id="CD000406-sec-0055"> <h5 class="title">1. Change in weight or height or BMI or z score or other indices of nutrition or growth</h5> <section id="CD000406-sec-0056"> <h6 class="title">a. Change in weight</h6> <p>There was no significant difference between the groups at any time point (<a href="./references#CD000406-fig-0001" title="">Analysis 1.1</a>); although data from two trials showed a trend for the supplement group to have greater improvement at three months, MD 0.32 kg (95% CI ‐0.09 to 0.72) (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>), and from two trials at six months MD 0.47 kg (95% CI ‐0.07 to 1.02) (<a href="./references#CD000406-bbs2-0001" title="HanningRM , BlimkieCJR , Bar-OrO , LandsLC , MossLA , WilsonWM . Relationships among nutritional status and skeletal and respiratory muscle function in cystic fibrosis: does early dietary supplementation make a difference?American Journal of Clinical Nutrition1993;57(4):580-7. [CFGD REGISTER: GN41a] LandsLC , HeigenhauserGJF , Bar-OrO , BlimkeC , HanningR , WilsonWM , et al. The effect of early nutritional supplementation on respiratory function in cystic fibrosis (CF). American Review of Respiratory Disease1992;145:A115. [CFGD REGISTER: GN41b] ">Hanning 1993</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). However, this was not apparent from a single trial at 12 months, MD 0.16 kg (95% CI ‐0.68 to 1.00) (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). </p> </section> <section id="CD000406-sec-0057"> <h6 class="title">b. Change in weight centile</h6> <p>Data were only available from one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). There was no significant difference between the groups at three months, MD 1.72 percentile points (95% CI ‐0.59 to 4.03), at six months, MD 2.12 percentile points (95% CI ‐0.94 to 5.18) or 12 months, MD 1.83 percentile points (95% CI ‐1.77 to 5.43) (<a href="./references#CD000406-fig-0002" title="">Analysis 1.2</a>). </p> </section> <section id="CD000406-sec-0058"> <h6 class="title">c. Change in height</h6> <p>There was no significant difference between the groups at three months (two trials (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD ‐0.04 cm (95% CI ‐0.36 to 0.29), at six months (one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD ‐0.47 cm (95% CI ‐1.32 to 0.38) or at 12 months (one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD 0.06 cm (95% CI ‐0.50 to 0.62) (<a href="./references#CD000406-fig-0003" title="">Analysis 1.3</a>). </p> </section> <section id="CD000406-sec-0059"> <h6 class="title">d. Change in height centile</h6> <p>Data were only available from one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). Analysis showed no significant difference between the groups at three months, MD ‐0.56 percentile points (95% CI ‐2.04 to 0.92), at six months, MD ‐1.74 percentile points (95% CI ‐4.40 to 0.92) or at 12 months, MD ‐0.65 percentile points (95% CI ‐3.11 to 1.81) (<a href="./references#CD000406-fig-0004" title="">Analysis 1.4</a>). </p> </section> <section id="CD000406-sec-0060"> <h6 class="title">e. Weight for height</h6> <p>Data were only available from one trial (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>); at three months there was no significant difference between the groups, MD ‐0.96% (95% CI ‐5.23 to 3.31) (<a href="./references#CD000406-fig-0005" title="">Analysis 1.5</a>). </p> </section> <section id="CD000406-sec-0061"> <h6 class="title">f. Change in BMI</h6> <p>Data were only available from one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). There was no significant difference between the groups at three months, MD 0.14 kg/m² (95% CI ‐0.08 to 0.36), at six months, MD 0.24 kg/m² (95% CI ‐0.06 to 0.54) or at 12 months, MD 0.08 kg/m² (95% CI ‐0.28 to 0.44) (<a href="./references#CD000406-fig-0006" title="">Analysis 1.6</a>). </p> </section> <section id="CD000406-sec-0062"> <h6 class="title">g. Change in BMI centile</h6> <p>Data were only available from one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). There was no significant difference between the groups at three months, MD 3.28 percentile points (95% CI ‐0.70 to 7.26), at six months, MD 5.75 percentile points (95% CI 0.22 to 11.28) or at 12 months, MD 2.99 percentile points (95% CI ‐2.69 to 8.67) (<a href="./references#CD000406-fig-0007" title="">Analysis 1.7</a>). </p> </section> </section> </section> <section id="CD000406-sec-0063"> <h4 class="title">Secondary outcomes</h4> <section id="CD000406-sec-0064"> <h5 class="title">1. Anthropometric measures of body composition</h5> <section id="CD000406-sec-0065"> <h6 class="title">a. Change in mid‐upper arm circumference</h6> <p>Data were only available from one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). There was no significant difference between the groups at three months, MD 0.19 cm (95% CI ‐0.25 to 0.63), at six months, MD 0.22 cm (95% CI ‐0.17 to 0.61) or at 12 months, MD 0.21 cm (95% CI ‐0.27 to 0.69) (<a href="./references#CD000406-fig-0008" title="">Analysis 1.8</a>). </p> </section> </section> <section id="CD000406-sec-0066"> <h5 class="title">2.Total calorie intake measured daily or weekly or over some other time interval</h5> <section id="CD000406-sec-0067"> <h6 class="title">a. Change in total calorie intake</h6> <p>There was no significant difference between the groups at three months (two trials (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD 115.09 Kcal (95% CI ‐121.34 to 351.52) (<a href="./references#CD000406-fig-0009" title="">Analysis 1.9</a>). Data at six months and 12 months were only reported in one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>); these data showed that the total calorie intake recorded in the supplement group was greater; at six months, MD 304.86 Kcal (95% CI 5.62 to 604.10), and at 12 months, MD 265.70 Kcal (95% CI 42.94 to 488.46) (<a href="./references#CD000406-fig-0009" title="">Analysis 1.9</a>). </p> </section> <section id="CD000406-sec-0068"> <h6 class="title">b. Change in total protein intake</h6> <p>There was no significant difference between the groups at three months (two trials (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD 2.51 g/day (95% CI ‐6.74 to 11.77), at six months (one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD 8.77 g/day (95% CI ‐1.24 to 18.78) or at 12 months (one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD 6.82 g/day (95% CI ‐2.36 to 16.00) (<a href="./references#CD000406-fig-0010" title="">Analysis 1.10</a>). </p> </section> <section id="CD000406-sec-0069"> <h6 class="title">c. Change in total fat intake</h6> <p>There was no significant difference between the groups at three months (two trials (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD ‐1.10 g/day (95% CI 15.05 to 12.85), at six months (one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD 11.74 g/day (95% CI ‐2.96 to 6.44) or at 12 months (one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD 8.85 g/day (95% CI ‐4.64 to 22.34) (<a href="./references#CD000406-fig-0011" title="">Analysis 1.11</a>). </p> </section> </section> <section id="CD000406-sec-0070"> <h5 class="title">3. Calorie intake from food measured daily, weekly or over some other time interval</h5> <p>No study reported this outcome measure.</p> </section> <section id="CD000406-sec-0071"> <h5 class="title">4. Calorie intake from OCS measured daily, weekly or over some other time interval</h5> <p>This outcome was only reported in one trial; at the three‐month time point, mean (SD) calorie intake per day from supplements was 126.8 (387.7) Kcal in the supplement group (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>). </p> </section> <section id="CD000406-sec-0072"> <h5 class="title">5. Nutrient intake measured daily, weekly or at some other time interval</h5> <p>No trial reported this outcome measure.</p> </section> <section id="CD000406-sec-0073"> <h5 class="title">6. Measures of eating behaviour</h5> <p>No trial reported this outcome.</p> </section> <section id="CD000406-sec-0074"> <h5 class="title">7. Measures of quality of life</h5> <p>No trial reported this outcome.</p> </section> <section id="CD000406-sec-0075"> <h5 class="title">8. Adverse effects including diarrhoea, reduced appetite, abdominal bloating, episodes of distal intestinal obstruction syndrome and any other adverse effects reported </h5> <p>The CALICO trial investigated gastro‐intestinal symptoms with a questionnaire and reported no significant difference between the groups (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). </p> </section> <section id="CD000406-sec-0076"> <h5 class="title">9. Measures of lung function</h5> <section id="CD000406-sec-0077"> <h6 class="title">a. Change in FEV₁ (% predicted)</h6> <p>At three months, the change in FEV₁ (% predicted) was greater in the control group (two trials (<a href="./references#CD000406-bbs2-0002" title="KalninsD , CoreyM , EllisL , PencharzPB , TullisE , DuriePR . Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis. Journal of Pediatrics2005;147(3):399-401. KalninsD , DuriePR , CoreyM , EllisL , PencharzP , TullisE . Are oral dietary supplements effective in the nutritional management of adolescents and adults with CF?Pediatric Pulmonology1996;Suppl 11:314-5. KalninsD , DuriePR . Oral supplements vs normal food intake in children and adults. Israel Journal of Medical Sciences1996;32:S120-S121. ">Kalnins 2005</a>; <a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD ‐7.96% (95% CI ‐13.52 to ‐2.40), but there was no significant difference between groups at six months (one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD ‐3.39% (95% CI ‐9.97 to 3.19) (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>), or at 12 months (one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>)), MD ‐1.91% (95% CI ‐8.57 to 4.75) (<a href="./references#CD000406-fig-0012" title="">Analysis 1.12</a>). </p> </section> <section id="CD000406-sec-0078"> <h6 class="title">b. Change in FVC (% predicted)</h6> <p>Data were only available from one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). There was no significant difference between the groups at three months, MD 0.12% (95% CI ‐9.17 to 9.41), at six months, MD ‐0.13% (95% CI ‐9.07 to 8.81) or at 12 months, MD 5.27% (95% CI ‐3.67 to 14.21) (<a href="./references#CD000406-fig-0013" title="">Analysis 1.13</a>). </p> </section> </section> <section id="CD000406-sec-0079"> <h5 class="title">10. Number of deaths or age at death in each group</h5> <p>None of the trials reported any deaths.</p> <section id="CD000406-sec-0080"> <h6 class="title">11. Activity levels (post‐hoc change)</h6> <p>Data were only available from one trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). There was no significant difference between the groups at three months, MD 0.52% in 24 hours (95% CI ‐3.89 to 4.93), at six months, MD ‐1.84% in 24 hours (95% CI ‐6.38 to 2.70) or at 12 months, MD ‐0.08% in 24 hours (95% CI ‐4.05 to 3.89) (<a href="./references#CD000406-fig-0014" title="">Analysis 1.14</a>). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000406-sec-0081" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000406-sec-0081"></div> <section id="CD000406-sec-0082"> <h3 class="title" id="CD000406-sec-0082">Summary of main results</h3> <p>This Cochrane Review has shown that use of oral protein energy supplements does not improve nutritional status in people with cystic fibrosis (CF). It suggests that dietary advice alone is a satisfactory approach to the management of people with CF and moderate malnutrition. This has implications for the nutritional management of CF as these products are widely prescribed and are expensive. We feel that oral protein calorie supplements should not be regarded as an essential part of the long‐term clinical care of children with CF who are moderately malnourished. </p> </section> <section id="CD000406-sec-0083"> <h3 class="title" id="CD000406-sec-0083">Overall completeness and applicability of evidence</h3> <p>There are some issues which should be considered when assessing the implications of the review for clinical practice. Firstly, the result of this review was largely contributed to by the CALICO study (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). This study was conducted in children, not adults, who were moderately malnourished and the intervention given was in the form of oral protein energy supplements, taken as drinks, over the long term. The children generally had good lung function (mean forced expiratory volume in one second (FEV₁) % predicted was greater than 70%) and did not have severe complications of CF. Therefore one must be cautious in considering whether the results of this review can be applied to adults with more severe lung disease or worse nutritional status or both. Additionally, the short‐term use of nutritional supplements as a strategy to treat acute weight loss was not assessed in any other trial included in this review. </p> <p>Total energy and macronutrient intake in the included trials were assessed by information from diaries. The investigators in the CALICO trial reviewed this carefully and felt that the diary information was likely to be an overestimate of the participants' intake from supplements, as supplement groups seemed to be consuming about 18% more than the standard care group relative to their estimated average requirement for energy intake, but showed no change in nutritional status. Hence reported intake of food and other nutrients by participants should be interpreted with caution in clinical studies. </p> </section> <section id="CD000406-sec-0084"> <h3 class="title" id="CD000406-sec-0084">Quality of the evidence</h3> <p>The quality of the evidence was judged to be moderate for the change in weight and height and low for the change in total calories, total fat and total protein intake (this is because results are applicable only to children between the ages of two and 15 years and many post‐treatment diet diaries were not returned). Evidence for the rate of adverse events in the treatment groups was extremely limited and judged to be of very low quality. </p> </section> <section id="CD000406-sec-0085"> <h3 class="title" id="CD000406-sec-0085">Potential biases in the review process</h3> <p>The authors undertook comprehensive searching for this review so there is unlikely to be any bias due to the non‐identification of relevant trials. However, the lead author of the review was also an investigator on the largest included study in the review. To avoid any potential bias from this fact data from that study were extracted and checked by an independent person at the editorial base. </p> </section> <section id="CD000406-sec-0086"> <h3 class="title" id="CD000406-sec-0086">Agreements and disagreements with other studies or reviews</h3> <p>Despite the findings of this review, guidelines from the USA (<a href="./references#CD000406-bbs2-0023" title="Cystic Fibrosis Foundation. Nutrition in Children and Adults Clinical Care Guidelines. www.cff.org/For-Caregivers/Clinical-Care-Guidelines/Nutrition-and-GI-Clinical-Care-Guidelines/Nutrition-in-Children-and-Adults-Clinical-Care-Guidelines/ (accessed 01 December 2016).">CFF 2016</a>) and the UK (<a href="./references#CD000406-bbs2-0033" title="UK Cystic Fibrosis Trust. Nutrition: A guide for adults with cystic fibrosis. www.cysticfibrosis.org.uk/life-with-cystic-fibrosis/publications/factsheets (accessed 01 December 2016).">UK CF Trust 2010</a>; <a href="./references#CD000406-bbs2-0034" title="UK Cystic Fibrosis Trust. Nutrition: a guide for children and parents. www.cysticfibrosis.org.uk/life-with-cystic-fibrosis/publications/factsheets (accessed 01 December 2016).">UK CF Trust 2013</a>) continue to provide recommendations for their use, although the statements made are not specific about the clinical situation in which they should be used. A non‐Cochrane systematic review states, "For children with growth deficits and adults with weight deficits, the CF Foundation recommends the use of nutritional supplements (oral and enteral) in addition to usual dietary intake to improve the rate of weight gain" (<a href="./references#CD000406-bbs2-0032" title="StallingsVA , StarkLJ , RobinsonKA , FeranchakAP , QuintonH , Clinical Practice Guidelines on Growth and Nutrition Subcommittee, Ad Hoc Working Group. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. Journal of the American Dietetic Association2008;108(5):832-9. [DOI: 10.1016/j.jada.2008.02.020]">Stallings 2008</a>), but does not reference this Cochrane Review or the CALICO trial (<a href="./references#CD000406-bbs2-0003" title="PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL , on behalf of the CALICO Trial Collaborative Group. Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial. BMJ2006;332(7542):632-6. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Baseline characteristics of children participating in the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S79. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRL . Recruitment of children to the CALICO trial of oral calorie supplements for cystic fibrosis. Journal of Cystic Fibrosis2004;3(Suppl 1):S76. PoustieVJ , RussellJE , WatlingRM , AshbyD , SmythRS . The CALICO multi-centre randomised controlled trial of oral calorie supplements for children with cystic fibrosis. Pediatric Pulmonology2004;38(Suppl 27):333. ">Poustie 2006</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000406-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 1: Change in weight (kg)" data-id="CD000406-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 1: Change in weight (kg) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 2: Change in weight centile (percentile points)" data-id="CD000406-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 2: Change in weight centile (percentile points) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 3: Change in height (cm)" data-id="CD000406-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 3: Change in height (cm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 4: Change in height centile (percentile points)" data-id="CD000406-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 4: Change in height centile (percentile points) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 5: Change in weight for height (percentage)" data-id="CD000406-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 5: Change in weight for height (percentage) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 6: Change in BMI (kg/m2)" data-id="CD000406-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 6: Change in BMI (kg/m2) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 7: Change in BMI centile (percentile points)" data-id="CD000406-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 7: Change in BMI centile (percentile points) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 8: Change in mid‐upper arm circumference (cm)" data-id="CD000406-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 8: Change in mid‐upper arm circumference (cm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 9: Change in total Kcal/day" data-id="CD000406-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 9: Change in total Kcal/day </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 10: Change in total protein (g)/day" data-id="CD000406-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 10: Change in total protein (g)/day </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 11: Change in total fat (g)/day" data-id="CD000406-fig-0011" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 11: Change in total fat (g)/day </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 12: Change in FEV₁ (% predicted)" data-id="CD000406-fig-0012" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 12: Change in FEV₁ (% predicted) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 13: Change in FVC (% predicted)" data-id="CD000406-fig-0013" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 13: Change in FVC (% predicted) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000406-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/urn:x-wiley:14651858:media:CD000406:CD000406-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 14: Change in activity (% 24 hours)" data-id="CD000406-fig-0014" src="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_t/tCD000406-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Oral calorie supplements versus no intervention or additional nutritional advice, Outcome 14: Change in activity (% 24 hours) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/media/CDSR/CD000406/image_n/nCD000406-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000406-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Oral calorie supplements compared with control for cystic fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population</b>: adults and children with cystic fibrosis </p> <p><b>Settings</b>: outpatients </p> <p><b>Intervention</b>: oral calorie supplements </p> <p><b>Comparison</b>: control (no intervention, dietary advice or nutritional counselling) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Control (no intervention, dietary advice or nutritional counselling)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Oral calorie supplements</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in weight (kg):<sup>1</sup> </b> at 12 months </p> <p>Follow‐up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in weight was 2.97 kg gained in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in weight was 0.16 kg extra gained (0.68 kg lost to 1.00 kg extra gained) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was also no significant difference between treatment groups at 3 months (MD 0.32 kg, 95% CI ‐0.09 kg to 0.72 kg, 112 participants, 2 trials) or at 6 months (MD 0.47 kg, 95% CI ‐0.07 kg to 1.02 kg, 117 participants, 2 trials). </p> <p>There was also no significant difference in change in weight centile between treatment groups at 3, 6 and 12 months. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in height (cm):<sup>1</sup> </b> </p> <p>at 12 months</p> <p>Follow‐up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in height was 5.85 cm gained in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in height was 0.06 cm extra gained (0.50 cm lost to 0.62 cm extra gained) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>102</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>moderate<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was also no significant difference between treatment groups at 3 months (MD ‐0.04 cm, 95% CI ‐0.36 cm to 0.29 cm, 112 participants, 2 trials) or at 6 months (MD ‐0.47 cm, 95% CI ‐1.32 cm to 0.38 cm, 101 participants, 1 trial). </p> <p>There was also no significant difference in change in height centile between treatment groups at 3, 6 and 12 months. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in total calories (Kcal/day)</b>: </p> <p>at 12 months</p> <p>Follow‐up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total calories was 139.52 Kcal/day in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total calories was 265.70 Kcal/day higher (42.94 to 488.46 Kcal/day higher) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/>(1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was also a significant advantage to the treatment group over the control group at 6 months (MD 304.86 Kcal/day, 95% CI 5.62 kcal/day to 604.10 Kcal/day, 48 participants, 1 trial). </p> <p>There was no significant difference between treatment groups at 3 months (MD 115.09 Kcal/day, 95% CI ‐121.34 Kcal/day to 351.52 Kcal/day, 58 participants, 2 trials). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in total protein (g/day)</b>: </p> <p>at 12 months</p> <p>Follow‐up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total protein was 5.75 g/day in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total calories was 6.82 g/day higher (2.36 g/day lower to 16.00 g/day higher) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/>(1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was also no significant difference between treatment groups at 3 months (MD 2.51 g/day, 95% CI ‐6.74 g/day to 11.77 g/day, 58 participants, 2 trials) or at 6 months (MD 8.77 g/day, 95% CI ‐1.24 g/day to 18.78 g/day, 48 participants, 1 trial). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in total fat (g/day)</b>: </p> <p>at 12 months</p> <p>Follow up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total fat was 12.23 g/day in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in total calories was 8.85 g/day higher (4.64 g/day lower to 22.34 g/day higher) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58<br/>(1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>2,3</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was also no significant difference between treatment groups at 3 months (MD ‐1.10 g/day, 95% CI ‐15.05 g/day to 12.85 g/day, 58 participants, 2 trials) or at 6 months (MD 11.74 g/day, 95% CI ‐2.96 g/day to 26.44 g/day, 48 participants, 1 trial). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b>: </p> <p>Follow up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not stated</p> <p>(1 trial)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>very low<sup>4</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One trial investigated gastro‐intestinal symptoms with a questionnaire and reported no significant difference between the groups. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Change in lung function ‐ FEV₁ (% predicted):</b> </p> <p>at 12 months</p> <p>Follow‐up: up to 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in FEV₁ (% predicted) was ‐1.5 in the control group.</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in FEV₁ (% predicted) 1.91 lower (8.57 lower to 4.75 higher) in the treatment group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>70<br/>(1 trial) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>low<sup>2,5</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>There was a significant decline in FEV₁ (% predicted) in the treatment group compared to the control group at 3 months (MD ‐7.96, 95% CI ‐13.52 to ‐2.40). There was no significant difference between treatment groups at 6 months (MD ‐3.39, 95% CI ‐9.97 to 3.19). </p> <p>There was also no significant difference in change in FVC between treatment groups at 3, 6 and 12 months. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the mean control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>BMI</b> : body mass index; <b>CI</b> : confidence interval; <b>FEV₁</b> : forced expiratory volume at 1 second; <b>FVC</b> : forced vital capacity; <b>MD</b> : mean difference; <b>NA</b>: not applicable </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality</b> : further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality</b> : further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality</b> : further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality</b>: we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1. There was also no significant difference in terms of other indices of nutrition or growth; weight for height (percentage) at 3 months, change in BMI (kg/m²) at 3, 6 and 12 months and change in BMI centile at 3 and 12 months. There was a significant advantage for oral calorie supplements over control at 6 months (MD 5.75, 95% CI 0.22 to 11.28, 101 participants, 1 trial). </p> <p>2. Downgraded once due to applicability; results apply only to children between the ages of 2 and 15 years, results not applicable to adults. </p> <p>3. Downgraded once due to incomplete outcome data; 58 out of 102 children returned the 12 month dietary diary, 44 who did not return the diary are excluded from analysis. </p> <p>4. Downgraded twice due to imprecision and once due to risk of selective outcome reporting bias; adverse events of treatment were reported in only a single trial and very limited information was provided about the rate of adverse events. </p> <p>5. Downgraded once due to applicability; Spirometry data recorded only for children over the age of 5 years, lung function outcomes are not applicable to children between the ages of 2 to 5 years from this study. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/full#CD000406-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000406-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Oral calorie supplements versus no intervention or additional nutritional advice</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Change in weight (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [‐0.09, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.47 [‐0.07, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.68, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Change in weight centile (percentile points) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Change in height (cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.36, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.47 [‐1.32, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.50, 0.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Change in height centile (percentile points) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Change in weight for height (percentage) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Change in BMI (kg/m2) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Change in BMI centile (percentile points) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Change in mid‐upper arm circumference (cm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Change in total Kcal/day <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>115.09 [‐121.34, 351.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>304.86 [5.62, 604.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>265.70 [42.94, 488.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Change in total protein (g)/day <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.51 [‐6.74, 11.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.77 [‐1.24, 18.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.82 [‐2.36, 16.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Change in total fat (g)/day <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.10 [‐15.05, 12.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.74 [‐2.96, 26.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.85 [‐4.64, 22.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Change in FEV₁ (% predicted) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.96 [‐13.52, ‐2.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.39 [‐9.97, 3.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.91 [‐8.57, 4.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 Change in FVC (% predicted) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 Change in activity (% 24 hours) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Oral calorie supplements versus no intervention or additional nutritional advice</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000406.pub5/references#CD000406-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000406.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD000406-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD000406-note-0009">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000406-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD000406-note-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD000406-note-0006">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000406\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000406\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000406\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000406\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000406\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000406.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000406.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000406.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000406.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000406.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717490425"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000406.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717490429"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000406.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918db9357f5c9365',t:'MTc0MDcxNzQ5MC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 